FindTrial
Sign In

New parallel technology for diagnosis of HIV, HBV, HCV based on magnetic nanoparticle extraction and chemiluminescence method

New parallel technology for diagnosis of HIV, HBV, HCV based on magnetic nanoparticle extraction and chemiluminescence method

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-14005151
Enrollment
Unknown
Registered
2014-08-25
Start date
2014-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV,HBV,HCV

Interventions

Gold Standard:
Index test:

Sponsors

Jiangsu Province Blood Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: (1)Informed consent; (2)Aged between 18 and 120.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
HBV Ag;HCV Ag;—

Contacts

Public ContactWenbiao LIANG
thibaut@126.com+86 18913826070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026